Observational Study of RHINOSEDAL in Acute Nasal Obstruction

This prospective, multicenter, national, observational, non-interventional post-market clinical follow-up study evaluates the performance and safety of RHINOSEDAL in children and adults presenting with acute nasal obstruction associated with common cold, allergic or non-allergic rhinitis, or rhinosinusitis. Patients prescribed RHINOSEDAL in routine care will be followed for 6 ±1 days using patient-reported outcome measures including the NOSE score.

NCT Number	NCT07620522
Lead Sponsor	Laboratoires Elerte Collaborators: Clin-Experts
Conditions	Nasal Obstruction, Common Cold, Allergic Rhinitis, Non-allergic Rhinitis, Rhinosinusitis
Enrollment	126 participants
Start Date	2026-10-15
Primary Completion	2027-10-31 (estimated)
Study Completion	2027-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-06-02